Formulary Search - PAD Formulary

PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > Formulary Search

BNF Chapter

BNF Paragraph

Please select a BNF Chapter.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Oedema (Brolucizumab - Diabetic macular oedema)

Records returned : 6 (on 22 Nov 2024 at 07:04:21). Return to search results for ' Oedema '.

Drug

Indication

Status

Trust Alignment

Links

Restrictions/Comments

Brolucizumab

Diabetic macular oedema

Red

Formulations :

Intravitreal injection

ASPH

RSFT

SASH

SABP

Primary Care

BNF NICE SPC

ICB

BlueTeq

NICE

Faricimab

Diabetic macular oedema

Red

Formulations :

Intravitreal injection

ASPH

RSFT

SASH

SABP

Primary Care

BNF NICE SPC

ICB

BlueTeq

NICE

11.04.01

Fluocinolone acetonide

Diabetic macular oedema

Red

Formulations :

Intravitreal implant

ASPH

RSFT

SASH

SABP

Primary Care

BNF NICE SPC

ICB

BlueTeq

NICE

Important

Ophthalmology specialists only. In patients who have failed to respond to prior treatments.

04.06.00

11.04.01

Dexamethasone

Diabetic macular oedema

Red

Formulations :

Intravitreal implant

ASPH

RSFT

SASH

SABP

Primary Care

BNF NICE SPC

ICB

BlueTeq

NICE

Important

Ophthalmology specialists only

Aflibercept

Diabetic macular oedema

Red

Formulations :

Not Specified

ASPH

RSFT

SASH

SABP

Primary Care

BNF NICE SPC

ICB

BlueTeq

NICE

11.08.02

Ranibizumab

Diabetic macular oedema

Red

Formulations :

Intravitreal injection

ASPH

RSFT

SASH

SABP

Primary Care

BNF NICE SPC

ICB

BlueTeq

NICE

For information about the icons and status values within this site, please refer to the keys below.

Icon/Links Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off-label use. Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

ICB

Treatment commissioned by the ICB

BlueTeq

BlueTeq form to be completed

NICE

Traffic Light Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Black

Now referred to as "Non Formulary" but some BLACK drugs remain pending review. Not recommended for use in any health setting across Surrey and NW Sussex health economy.

Amber Star

Now referred to as "Blue" but some Amber Star drugs remain pending review. Prescribing initiated and stabliised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across Surrey and NW Sussex health economy. (Formerly BLACK traffic light status)

See Below

Please add a description.

N/A

Please add a description.

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

Green - Black

Now referred to as "Do not initiate in new patients" but some GREEN/BLACK drugs remain pending review. These drugs are NOT for new initiations (BLACK, (now referred to as Non Formulary)) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required.

See narrative

See narrative - is applied in instances where there may be more than one traffic light status for a drug. This occurs when the traffic light status may differ between specific cohorts of patients e.g. those of childbearing potential and those who are not (in the case of sodium valproate)

Do not initiate in new patients

These drugs are NOT for new initiations (Non Formulary) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required. (Formerly GREEN/BLACK traffic light status)